After an unsuccessful WHO inspection, Panacea Biotech sought assistance from PCS to enhance their WHO GMP quality system. Through prompt remediation and interim corporate Quality Assurance services over several years, PCS aided Panacea in restoring its previous level of GMP standards, enabling the company to resume the production and delivery of various vaccine products to the WHO.
Download our training brochure for 2026 by clicking this link
We use cookies to improve your experience, analyze website usage, and show you relevant information. By accepting all cookies, you help us improve the website. View our privacy statement.
Cookie settings
Necessary
Always active. Required for the website to function properly.
Statistics
Helps us improve the website through anonymous statistics.
Marketing
For third-party marketing and tracking cookies.